More than 15 years experience in professional health policy management, market access, public affairs and corporate communications Specialties: Political campaigning, Market Access Strategies, Pricing & reimbursement of pharmaceutical innovation, European Healthcare Policy, Stakeholder Management, Professional negotiation

APAC Head of Regional Market Access, Policy and Pricing @ From September 2015 to Present (4 months) Vice President Market Access @ Doing now what patients need next. From February 2013 to August 2015 (2 years 7 months) Senior Director Customer Affairs & Access @ Lead of customer affairs & access department (within market access)/act as professional business partner for commercial units and interface to european and global market access and public affairs teams with focus on the development and implementation of payer and access strategies. From December 2010 to January 2013 (2 years 2 months) Director Market Access & Healthcare Policy @ Development & implementation of market access strategies for established brands and pipeline products/optimize pricing & reimbursement/negotiations with payers/public affairs and stakeholder management/lead of cross-functional access teams/patient advocacy From December 2009 to December 2010 (1 year 1 month) General Secretary @ General Secretary of the Austrian LAWG/ implementation of professional network to reimbursement authorities, payers and health politicians on national and european level/development and execution of advocacy programs in order to ensure fast access to innovations/head of strategic working group for market access policies with focus on HTA, risk sharing and biosimilars/interface and link to interest organizations like EFPIA, PhRMA and American Chamber of Commerce From March 2007 to June 2010 (3 years 4 months) Head of Public Affairs @ Development of national pricing policies and strategies/development of 3rd party advocates, coalition building and agenda setting strategies as part of reputation management/ ensure implementation of pricing policies and strategies across all business units for achieving rapid market access at optimal prices in line with strategy/analysis of trends in pricing and reimbursement with special focus on risk-sharing, HTA and conditional reimbursement, From September 2006 to November 2009 (3 years 3 months) Head of Corporate Communications & Public Affairs @ Corporate brand management/head of marketing for rx- and OTC product portfolio/press & media relations and CEO reputation management/ analysis of health care policies in Austria; foundation of “Politics meets Science” (high level forum in cooperation with MoH and Austrian Society of Public Health )/establish and manage network to payers From December 2002 to August 2006 (3 years 9 months) General Secretary @ Strategic public affairs management/co-representative of generic industry during health care reform 2003/2004/campaign management & development of public information campaign for generics in cooperation with MOH, sick funds, chamber of physicians, chamber of pharmacists/foundation of working groups with local sick funds/Egagenerics in order to develop measures and programs to enhance generic prescription in Austria From March 2003 to June 2006 (3 years 4 months)

2006, Integrated Communications @ Donau-Universität Krems From 2004 to 2006 2001, Public Affairs Management @ University Vienna From 1999 to 2001 2001, International Business Economics @ University of Vienna From 1997 to 2001 Michael Oberreiter is skilled in: Market Access, Negotiation, Pricing, Stakeholder Management, Pharmaceutical Industry, Health Economics, Lifesciences, Oncology, Life Sciences, Strategy, Biotechnology, Cross-functional Team Leadership, Sales Effectiveness, Pharmaceutical Sales, Strategic Negotiations, Clinical Trials